The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Phosphorylation of Thr 495 Regulates Ca 2+ /Calmodulin-Dependent Endothelial Nitric Oxide Synthase Activity
Abstract
Abstract —The activity of the endothelial nitric oxide synthase (eNOS) can be regulated independently of an increase in Ca 2+ by the phosphorylation of Ser 1177 but results only in a low nitric oxide (NO) output. In the present study, we assessed whether the agonist-induced (Ca 2+ -dependent, high-output) activation of eNOS is associated with changes in the phosphorylation of Thr 495 in the calmodulin (CaM)-binding domain. eNOS Thr 495 was constitutively phosphorylated in porcine aortic endothelial cells and was rapidly dephosphorylated after bradykinin stimulation. In the same cells, bradykinin enhanced the phosphorylation of Ser 1177 , which was maximal after 5 minutes, and abolished by the CaM-dependent kinase II (CaMKII) inhibitor KN-93. Bradykinin also enhanced the association of CaMKII with eNOS. Phosphorylation of Thr 495 was attenuated by the protein kinase C (PKC) inhibitor Ro 31-8220 and after PKC downregulation using phorbol 12-myristate 13-acetate. The agonist-induced dephosphorylation of Thr 495 was completely Ca 2+ -dependent and inhibited by the PP1 inhibitor calyculin A. Little CaM was bound to eNOS immunoprecipitated from unstimulated cells, but the agonist-induced dephosphorylation of Thr 495 enhanced the association of CaM. Mutation of Thr 495 to alanine increased CaM binding to eNOS in the absence of cell stimulation, whereas the corresponding Asp 495 mutant bound almost no CaM. Accordingly, NO production by the Ala 495 mutant was more sensitive to Ca 2+ /CaM than the aspartate mutant. These results suggest that the dual phosphorylation of Ser 1177 and Thr 495 determines the activity of eNOS in agonist-stimulated endothelial cells. Moreover, the dephosphorylation of Thr 495 by PP1 precedes the phosphorylation of Ser 1177 by CaMKII. The full text of this article is available at http://www.circresaha.org.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In resting endothelial cells, Thr495 is generally phosphorylated”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“The phosphorylation has been attributed to protein kinase C (PKC) (297, 646), and the residue is dephosphorylated by protein phosphatase 1 (PP1)”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
In the citing paper
“Phosphorylation of Thr495 is a negative regulator of CaM binding to eNOS (297, 407, 646).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [297]
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
Self-citationCloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase
Bredt, D. S., Hwang, P. M., Glatt, C. E., Lowenstein, C. J., Reed, R. R., & Snyder, S. H. (1991) · Nature · doi:10.1038/351714a0 · Cited by 2,354
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 839
Self-citationNishida, K., Harrison, D. G., Navas, J. P., Fisher, A. A., Dockery, S., Uematsu, M., Nerem, R. M., Alexander, R. W., & Murphy, T. J. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116092 · Cited by 735
García‐Cardeña, G., Fan, R., Stern, D. F., Liu, J., & Sessa, W. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.44.27237 · Cited by 533
Phosphorylation of Endothelial Nitric Oxide Synthase in Response to Fluid Shear Stress
Corson, M. A., James, N. L., Latta, S. E., Nerem, R. M., Berk, B. C., & Harrison, D. G. (1996) · Circulation Research · doi:10.1161/01.res.79.5.984 · Cited by 521
Calcium‐dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin
Busse, R., & Mülsch, A. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80902-u · Cited by 511
Self-citationMolecular cloning and characterization of human endothelial nitric oxide synthase
Marsden, P. A., Schappert, K. T., Chen, H. S., Flowers, M. A., Sundell, C. L., Wilcox, J. N., Lamas, S., & Michel, T. M. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80697-f · Cited by 489
Flagged first, then by citations
Research works printed but not linked: 5
- 10.1161/hyp.25.2.180 · DOI
- 10.1161/res.79.5.984 · DOI
- 10.1161/res.82.6.686 · DOI
- Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [published correction appears in Nature. 1999;400:792]. Nature. 1999;399:597–601.
- 10.1161/res.78.5.750 · DOI
Cited by
Sorted by citations
Items 301–400 of 770
Rezzani, R., Rodella, L. F., Dessy, C., Daneau, G., Bianchi, R., & Féron, O. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00898-6 · Cited by 44
S100A1: a Major Player in Cardiovascular Performance
Duarte-Costa, S., Castro‐Ferreira, R., Neves, J. S., & Leite-Moreira, A. F. (2014) · Physiological Research · doi:10.33549/physiolres.932712 · Cited by 42
“PKC phosphorylation of Thr(495) of eNOS is established as an inhibitory mechanism of eNOS activity (Fleming et al. 2001).”
Khan, M., Mohan, I. K., Kutala, V. K., Kotha, S. R., Parinandi, N. L., Hamlin, R. L., & Kuppusamy, P. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2155 · Cited by 44
Goubareva, I., Gkaliagkousi, Ε., Shah, A. M., Queen, L. R., RITTER, J., & Ferro, A. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.05.021 · Cited by 43
“In contrast, phosphorylation of Thr495 of NOS3 by protein kinase C (PKC) decreases its activity [ 6 ].”
BackgroundHernandez-Navarro, I., Botana, L., Diez-Mata, J., Tesoro, L., Jimenez-Guirado, B., Gonzalez-Cucharero, C., Alcharani, N., Zamorano, J. L., Saura, M., & Zaragoza, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189890 · Cited by 41
Liu, S., Premont, R. T., & Rockey, D. C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.320465 · Cited by 41
“Impaired endothelial NO release has been observed in a number of disease states, including pulmonary hypertension (11, 12), congestive heart failure (13), and portal hypertension (14, 15).”
BackgroundLong-Term Cyclic Strain Downregulates Endothelial Nox4
Goettsch, C., Göettsch, W., Arsov, A., Hofbauer, L. C., Bornstein, S. R., & Morawietz, H. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2561 · Cited by 41
Govers, R., van der Sluijs, P., van Donselaar, E. G., Slot, J.-W., & Rabelink, T. J. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205000604 · Cited by 41
“Other potential mechanisms that may be responsible for this include phosphorylation (Fleming et al. 2001) and the (local) absence of factors that are required for its enzymatic activity (e.g., calcium, l -arginine, and tetrahydrobiopterin). eNOS that is present in the Golgi complex does not…”
BackgroundInduction of microRNA‐138 by pro‐inflammatory cytokines causes endothelial cell dysfunction
Sen, A., Most, P., & Peppel, K. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.01.033 · Cited by 40
Zhang, W., Li, H., Dong, H., Liao, J., Hammock, B. D., & Yang, G.-Y. (2013) · PubMed · Cited by 40
Tran, Q., Firkins, R., Giles, J. R., Francis, S., Matnishian, V., Tran, P. N., VerMeer, M., Jasurda, J. S., Burgard, M., & Gebert‐Oberle, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697334 · Cited by 40
“Thr-497 is located in the CaM-binding domain of eNOS, and its phosphorylation status directly affects CaM binding to eNOS; dephosphorylation at Thr-497 promotes CaM binding, whereas phosphorylation at this site prevents CaM-eNOS interaction (35).”
BackgroundBiwer, L. A., Taddeo, E. P., Kenwood, B. M., Hoehn, K. L., Straub, A. C., & Isakson, B. E. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.04.014 · Cited by 40
Lin, Q., Zhao, L., Jing, R., Trexler, C. L., Wang, H., Li, Y., Tang, H., Huang, F. P., Zhang, F., Fang, X., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011704 · Cited by 39
Gould, N. R., Williams, K. M., Joca, H. C., Torre, O. M., Lyons, J. S., Leser, J. M., Srikanth, M. P., Hughes, M., Khairallah, R. J., Feldman, R. A., et al. (2021) · eLife · doi:10.7554/elife.64393 · Cited by 40
Compartmentalized nitric oxide signaling in the resistance vasculature
Mutchler, S. M., & Straub, A. C. (2015) · Nitric Oxide · doi:10.1016/j.niox.2015.05.003 · Cited by 40
Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis
Ercan, B., Ayaz, L., Çiçek, D., & Tamer, L. (2007) · Cell Biochemistry and Function · doi:10.1002/cbf.1437 · Cited by 40
Proteomics and signal transduction in the crustacean molting gland
Lee, S. G., & Mykles, D. L. (2006) · Integrative and Comparative Biology · doi:10.1093/icb/icl047 · Cited by 40
CD44/HA signaling mediates acquired resistance to a PI3Kα inhibitor
Yang, C., Sheng, Y., Shi, X., Liu, Y., He, Y., Du, Y., Zhang, G., & Gao, F. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03037-0 · Cited by 38
Stepanov, Y. V., Golovynska, I., Golovynskyi, S., Garmanchuk, L., Gorbach, O. I., Stepanova, L. I., Khranovska, N., Остапченко, Л. І., Ohulchanskyy, T. Y., & Qu, J. (2022) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2022.112388 · Cited by 39
Russo, I., Doronzo, G., Mattiello, L., Salve, A. D., Trovati, M., & Anfossi, G. (2004) · Thrombosis Research · doi:10.1016/j.thromres.2004.06.036 · Cited by 39
The Pulmonary Biology of Isoprostanes
Janssen, L. J., Catalli, A., & Helli, P. B. (2004) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.244 · Cited by 39
Kobayashi, T., Nemoto, S., Ishida, K., Taguchi, K., Matsumoto, T., & Kamata, K. (2012) · Clinical Science · doi:10.1042/cs20110621 · Cited by 38
Osuka, K., Watanabe, Y., Usuda, N., Atsuzawa, K., Yoshida, J., & Takayasu, M. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0836 · Cited by 38
“…(Chen et al., 1999). eNOS at Thr 495 is constitutively phosphorylated in porcine aortic endothelial cells and dephosphorylated by various stimuli (Fleming et al., 2001), in agreement with our finding that eNOS at Thr 495 is constitutively phosphorylated and gradually dephosphorylated after SAH.”
Xiao, Z., Wang, T., Qin, H., Huang, C., Feng, Y., & Xia, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.220236 · Cited by 38
Mesenchymal Stem Cells Induce Endothelial Activation via Paracine Mechanisms
Ladage, D., Brixius, K., Steingen, C., Mehlhorn, U., Schwinger, R. H. G., Bloch, W., & Schmidt, A. (2007) · Endothelium · doi:10.1080/10623320701343319 · Cited by 38
Transcriptional and Posttranslational Regulation of eNOS in the Endothelium
Fulton, D. J. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.04.001 · Cited by 37
Biomechanical Forces and Oxidative Stress: Implications for Pulmonary Vascular Disease
Zemskov, E. A., Lü, Q., Ornatowski, W., Klinger, C. N., Desai, A. A., Maltepe, E., Yuan, J. X. ‐., Wang, T., Fineman, J. R., & Black, S. M. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2018.7720 · Cited by 36
Igarashi, J., Miyoshi, M., Hashimoto, T., Kubota, Y., & Kosaka, H. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00117.2006 · Cited by 38
Dedkova, E. N., Ji, X., Wang, Y. G., Blatter, L. A., & Lipsius, S. L. (2003) · Circulation Research · doi:10.1161/01.res.0000106133.92737.27 · Cited by 38
Hyperoxia reduces basal release of nitric oxide and contracts porcine coronary arteries
Pasgaard, T., Stankevıčıus, E., Jørgensen, M. M., Østergaard, L., Simonsen, U., & Fröbert, O. (2007) · Acta Physiologica · doi:10.1111/j.1748-1716.2007.01745.x · Cited by 38
“The dephosphorylation of eNOS-Thr495 facilitates the binding of calmodulin to its binding domain and thus is a prerequisite for maximal NO production (Fleming et al. 2001).”
BackgroundChen, P., Tang, Y., He, W., Yang, R., Lan, Z., Chen, R., & Zhang, P. (2022) · Mediators of Inflammation · doi:10.1155/2022/7137900 · Cited by 40
Münzel, T. F., & Daiber, A. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2023.0006 · Cited by 40
Bibli, S., Zhou, Z., Zukunft, S., Fißlthaler, B., Andreadou, I., Szabó, C., Brouckaert, P., Fleming, I., & Papapetropoulos, A. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx058 · Cited by 36
Self-citationSu, J. B., Cazorla, O., Blot, S., Blanchard‐Gutton, N., Mou, Y. A., Barthélémy, I., Sambin, L., Sampedrano, C. C., Gouni, V., Unterfinger, Y., et al. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs161 · Cited by 38
Hu, Z., Xiong, Y., Han, X., Geng, C., Jiang, B., Huo, Y., & Luo, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071359 · Cited by 37
Warnholtz, A., Tsilimingas, N., Wendt, M., & Münzel, T. F. (2002) · Heart Failure Reviews · doi:10.1023/a:1020710417337 · Cited by 37
“Protein kinase C in turn may phosphorylate nitric oxide synthase leading to an inhibition of nitric oxide synthase activity and therefore to an inhibition of NO production by the enzyme [ 33 ], all of which may contribute to nitroglycerin-induced endothelial dysfunction.”
BackgroundLi, H., Förstermann, U., Xia, N., Kuntić, M., Münzel, T. F., & Daiber, A. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.009 · Cited by 38
Haouari, M. E. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867324666171005114456 · Cited by 37
CaMKII regulates intracellular Ca2+ dynamics in native endothelial cells
Toussaint, F., Charbel, C., Blanchette, A., & Ledoux, J. (2015) · Cell Calcium · doi:10.1016/j.ceca.2015.06.005 · Cited by 36
Microcirculatory Exchange Function
Durán, W. N., Sánchez, F. A., & Breslin, J. W. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00004-8 · Cited by 34
Molecular and clinical aspects of endothelial dysfunction in diabetes
Nacci, C., Tarquinio, M., & Montagnani, M. (2009) · Internal and Emergency Medicine · doi:10.1007/s11739-009-0234-7 · Cited by 36
“the flux of electrons through the reductase domain and the production of NO are increased up to three times above basal levels [ 3 ].”
BackgroundLǐ, Y., Xu, Q., Xu, W., Guo, X., Zhang, S., & Chen, Y. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.01.007 · Cited by 36
Randriamboavonjy, V., & Fleming, I. (2005) · PubMed · Cited by 36
Self-citationEndogenous Hemoprotein-Dependent Signaling Pathways of Nitric Oxide and Nitrite
Dent, M. R., DeMartino, A. W., Tejero, J., & Gladwin, M. T. (2021) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.1c01048 · Cited by 35
Decreased NO production in endothelial cells exposed to plasma from ME/CFS patients
Bertinat, R., Villalobos-Labra, R., Hofmann, L., Blauensteiner, J., Sepúlveda, N., & Westermeier, F. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.106953 · Cited by 35
Piezo1 opposes age‐associated cortical bone loss
Li, X., Zhang, C., Bowman, H. H., Stambough, J. B., Stronach, B. M., Mears, S. C., Barnes, L. C., Ambrogini, E., & Xiong, J. (2023) · Aging Cell · doi:10.1111/acel.13846 · Cited by 36
“Ca2+/CaM has been shown to regulate various signaling pathways including p38/MAPK, MEK/ERK, eNOS, and mTOR signaling (Agell et al., 2002; Fleming et al., 2001; Gulati et al., 2008; Krapivinsky et al., 2004).”
BackgroundSowden, H. M., Naseem, K. M., & Tobin, D. J. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06718.x · Cited by 35
Functional Significance of Cytosolic Endothelial Nitric-oxide Synthase (eNOS)
Sánchez, F. A., Rana, R. J., González, F. G., Iwahashi, T., Durán, R. G., Fulton, D. J., Beuve, A. V., Kim, D. D., & Durán, W. N. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234294 · Cited by 35
Napp, A., Brixius, K., Pott, C., Ziskoven, C., Boelck, B., Mehlhorn, U., Schwinger, R. H. G., & Bloch, W. (2008) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2008.08.006 · Cited by 35
Hyndman, K. A., Ho, D. H., Sega, M. F., & Pollock, J. S. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00243.2014 · Cited by 35
Prolactin activation of mammary nitric oxide synthase: molecular mechanisms
Bolander, F. F. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0280045 · Cited by 34
“However, the effects of PKC are controversial, with one group reporting NOS stimulation (Nakane et al. 1991) and others, inhibition (Bredt et al. 1992, Fleming et al. 2001 ).”
BackgroundStanišić, J., Korićanac, G., Ćulafić, T., Romić, S., Stojiljković, M., Kostić, M., Pantelić, M., & Tepavčević, S. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.11.032 · Cited by 36
Endothelial progenitor cells: Exploring the pleiotropic effects of statins
Sandhu, K., Mamas, M. A., & Butler, R. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i1.1 · Cited by 35
Wagner, L. J., Laczy, B., Tamaskó, M., Mazák, I., Markó, L., Molnár, G. A., Wagner, Z., Mohás, M., Cseh, J., Fekete, A., et al. (2007) · Endothelium · doi:10.1080/10623320701606707 · Cited by 34
Yang, Y., Nie, W., Yuan, J., Zhang, B., Wang, Z., Wu, Z., & Guo, Y. (2010) · Experimental & Molecular Medicine · doi:10.3858/emm.2010.42.11.078 · Cited by 34
“…genistein-induced eNOS activity, suggesting the existence of alternative signaling pathways that contributed to the phosphorylation of eNOS and related NO release. eNOS was initially reported to be phosphorylated on serine residues and has been studied in most detailed (Fleming et al., 2001).”
BackgroundEndothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase
Ramadoss, J., Pastore, M. B., & Magness, R. R. (2013) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12136 · Cited by 34
Nitric Oxide and Hormones In Breast Cancer: Allies Or Enemies?
Pance, A. (2006) · Future Oncology · doi:10.2217/14796694.2.2.275 · Cited by 34
Dossumbekova, A., Berdyshev, E. V., Gorshkova, I. A., Shao, Z., Li, C., Long, P., Joshi, A., Natarajan, V., & Hoek, T. L. V. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00501.2008 · Cited by 32
Chen, M., Yi, B., Zhu, N., Wei, X., Zhang, G., Huang, S., & Sun, J. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvv250 · Cited by 34
PRANDOTA, J. (2007) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000208272.42379.aa · Cited by 34
Aoki, C., Nakano, A., Tanaka, S., Yanagi, K., Ohta, S., Jojima, T., Kasai, K., Takekawa, H., Hirata, K., & Hattori, Y. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.029 · Cited by 34
“NO plays a significant role in vascular homeostasis and its bioavailability depends on several factors, including the expression level of endothelial nitric oxide synthase (eNOS) [12], the presence of substrate and cofactors for eNOS [13], the phosphorylation status of eNOS [14,15], and reaction with various reactive…”
BackgroundSoluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure
Sun, D., Cuevas, A. J., Gotlinger, K. H., Hwang, S. H., Hammock, B. D., Schwartzman, M. L., & Huang, A. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00920.2013 · Cited by 33
Georgiou, D. K., Dagnino-Acosta, A., Lee, C. S., Griffin, D. M., Wang, H. J., Lagor, W. R., Pautler, R. G., Dirksen, R. T., & Hamilton, S. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.643544 · Cited by 35
“activity (30, 31), Ca(2) /calmodulin (32), and CaMKII (33, 34).”
BackgroundLee, S.-J., Tsang, P. S., Diaz, T., Wei, B., & Stetler‐Stevenson, W. G. (2010) · Laboratory Investigation · doi:10.1038/labinvest.2009.136 · Cited by 33
(-)-Epicatechin-induced calcium independent eNOS activation: roles of HSP90 and AKT
Ramírez‐Sánchez, I., Aguilar, H., Ceballos, G. M., & Villarreal, F. J. (2012) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-012-1405-9 · Cited by 33
“Shear stress can also activate eNOS independently of large and sustained increases in [Ca]i, but this stimulation results in rather low NO production compared with agonist-evoked effects, where large increases in [Ca]i are induced [26].”
BackgroundZhang, T., Cui, B., Dai, D., & Su, W. C. (2005) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2005.00214.x · Cited by 33
Grayson, T., Chadha, P. S., Bertrand, P. P., Chen, H., Morris, M. J., Senadheera, S. N., Murphy, T. V., & Sandow, S. L. (2012) · Histochemistry and Cell Biology · doi:10.1007/s00418-012-1032-2 · Cited by 33
“…(and other serine/threonine kinases) which increases caveolin-1 binding and reduces calmodulin binding to eNOS (Bauer et al. 2003; Chen et al. 2008; Fleming et al. 2001; Li et al. 2007), and increased CK2 phosphorylation of calmodulin which attenuates calmodulin activation and displaces calmodulin…”
BackgroundSpectroscopic characterization of the iron-oxo intermediate in cytochrome P450
Jung, C., Schünemann, V., Lendzian, F., TRAUTWEIN, A. X., Contzen, J., Galander, M., Böttger, L. H., Richter, M., & Barra, A. (2005) · Biological Chemistry · doi:10.1515/bc.2005.120 · Cited by 33
Lee, S., Culberson, C., Korneszczuk, K., & Clemens, M. G. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00527.2007 · Cited by 33
Calpain 1 cleaves and inactivates prostacyclin synthase in mesenteric arteries from diabetic mice
Randriamboavonjy, V., Kyselova, A., Elgheznawy, A., Zukunft, S., Wittig, I., & Fleming, I. (2016) · Basic Research in Cardiology · doi:10.1007/s00395-016-0596-8 · Cited by 32
Self-citationJabs, A., Oelze, M. W., Mikhed, Y., Stamm, P., Kröller‐Schön, S., Welschof, P., Jansen, T., Hausding, M., Kopp, M., Steven, S., et al. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.007 · Cited by 34
CGRP signalling inhibits NO production through pannexin-1 channel activation in endothelial cells
Gaete, P. S., Lillo, M. A., Puebla, M., Poblete, I. M., & Figueroa, X. F. (2019) · Scientific Reports · doi:10.1038/s41598-019-44333-w · Cited by 32
Khalil, R. A. (2013) · Pharmaceuticals · doi:10.3390/ph6030407 · Cited by 32
“PKC may cause phosphorylation of Thr-495 and dephosphorylation of Ser-1175 in eNOS and in turn inhibit NO production [109,110].”
BackgroundA PP2A‐mediated feedback mechanism controls Ca 2+ ‐dependent NO synthesis under physiological oxygen
Keeley, T. P., Siow, R. C. M., Jacob, R., & Mann, G. E. (2017) · The FASEB Journal · doi:10.1096/fj.201700211r · Cited by 32
Queen, L. R., Ji, Y. H., Goubareva, I., & Ferro, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1219-0 · Cited by 32
“Phosphorylation of Thr 495 is generally associated with a decrease in enzyme activity [ 41 , 42].”
BackgroundPharmacological Efficacy of CPU 86017 on Hypoxic Pulmonary Hypertension in Rats
Zhang, T., Cui, B., Dai, D., & Tang, X. (2005) · Journal of Cardiovascular Pharmacology · doi:10.1097/01.fjc.0000184470.58047.79 · Cited by 32
Vanadyl sulfate inhibits NO production via threonine phosphorylation of eNOS.
Li, Z., Carter, J. D., Dailey, L. A., & Huang, Y.-C. T. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.6477 · Cited by 32
“Many agonist stimuli, such as vascular endothelial growth factor (VEGF) (Michell et al. 2001), bradykinin (Fleming et al. 2001; Harris et al. 2001), and ischemic stress (Chen ZP et al. 1999), inhibit phosphorylation at the Thr495 residue.”
BackgroundResultBaraúna, V. G., Mantuan, P. R., Magalhães, F. D. C., Campos, L. C. G., & Krieger, J. E. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.108 · Cited by 31
Statins in Endothelial Signaling and Activation
Jacobson, J. R. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2284 · Cited by 32
Nongenomic Estrogen Effects on Nitric Oxide Synthase Activity in Rat Adipocytes
Jaubert, A., Mehebik‐Mojaat, N., Lacasa, D., Sabourault, D., Giudicelli, Y., & Ribière, C. (2007) · Endocrinology · doi:10.1210/en.2006-1329 · Cited by 32
Daher, Z., Boulay, P.-L., Desjardins, F., Gratton, J., & Claing, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.115311 · Cited by 30
Insulin Regulates Nitric Oxide Production in the Kidney Collecting Duct Cells
Pandey, G., Makhija, E., George, N., Chakravarti, B., Godbole, M. M., ECELBARGER, C. A., & Tiwari, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.592741 · Cited by 30
“We have not directly assessed the activation of these kinases; however, studies done in other cell systems have not shown insulin stimulation of eNOS via calcium/calmodulin-dependent protein kinase II or PKA (47, 48).”
BackgroundZhu, J., Song, W., Xu, S., Ma, Y., Wei, B., Wang, H., & Hua, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00121 · Cited by 30
“Phosphorylation at Thr495 reduces the binding of CaM to eNOS, thereby inhibiting the activity of eNOS (Fleming et al., 2001), while phosphorylation at Ser1177 can enhance the catalytic ability of eNOS by inhibiting the separation of CaM from eNOS and enhancing the internal electron transfer rate of…”
BackgroundJarajapu, Y. P. R., Cai, J., Yan, Y., Calzi, S. L., Kielczewski, J. L., Hu, P., Shaw, L. C., Firth, S. M., Chan‐Ling, T., Boulton, M. E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039398 · Cited by 30
Grossini, E., Molinari, C. G., Mary, D., Uberti, F., Ribichini, F. L., Caimmi, P. P., & Vacca, G. (2009) · Cellular Physiology and Biochemistry · doi:10.1159/000204097 · Cited by 30
Role of Protease-Activated Receptor-1 in Endothelial Nitric Oxide Synthase-Thr495 Phosphorylation
Watts, V. L., & Motley, E. D. (2008) · Experimental Biology and Medicine · doi:10.3181/0807-rm-233 · Cited by 30
“Since bradykinin has been shown to induce eNOS-Thr495 phosphorylation via the bradykinin receptor, B1, we used bradykinin as a positive control (10, 11).”
MethodGrau, M., Lauten, A., Hoeppener, S., Goebel, B., Brenig, J., Jung, C., Bloch, W., & Suhr, F. (2016) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-162044 · Cited by 31
Phosphorylation of Akt at Thr308 regulates p‐eNOS Ser1177 during physiological conditions
Liang, X., Wang, R., Guo, Y., Cheng, Z., Lv, D., Luo, M., He, A., Luo, S., & Xia, Y. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13194 · Cited by 29
Park, J. Y., Choi, Y. W., Yun, J. W., Bae, J. U., Seo, K. W., Lee, S. J., Park, S. Y., & Kim, C. D. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.06.002 · Cited by 29
Mount, P. F., Fraser, S. A., Watanabe, Y., Lane, N., Katsis, F., Chen, Z., Kemp, B. E., & Power, D. A. (2005) · Nephron Physiology · doi:10.1159/000089092 · Cited by 29
Self-citationP2Y receptors as regulators of lung endothelial barrier integrity
Zemskov, E. A., Lucas, R., Verin, A. D., & Umapathy, N. S. (2011) · Journal of Cardiovascular Disease Research · doi:10.4103/0975-3583.78582 · Cited by 29
“[82,83] NO stimulates guanylate cyclase (GC), resulting in an elevation of second messenger cGMP levels and cGMPdependent protein kinase G (PKG) activation.”
BackgroundTargeting caveolin-3 for the treatment of diabetic cardiomyopathy
Murfitt, L., Whiteley, G., Iqbal, M. M., & Kitmitto, A. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.03.002 · Cited by 29
“Phosphorylation of Thr495 by PKC is proposed to be inhibitory by preventing calmodulin binding (Fleming et al., 2001).”
BackgroundInsulin Stimulates Nitric Oxide Production in Rat Adipocytes
Ribière, C., Jaubert, A., Sabourault, D., Lacasa, D., & Giudicelli, Y. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6444 · Cited by 29
Cyclin-Dependent Kinase 5 Phosphorylates Endothelial Nitric Oxide Synthase at Serine 116
Cho, D., Seo, J., Park, J., Jo, C., Choi, Y. J., Soh, J., & Jo, I. (2010) · Hypertension · doi:10.1161/hypertensionaha.109.140210 · Cited by 29
Chiasson, V. L., Quinn, M. A., Young, K. J., & Mitchell, B. M. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.178095 · Cited by 29
“PKC activation is known to decrease NO production, which may be mediated by its direct effects on eNOS phosphorylation sites (Fleming et al., 2001; Matsubara et al., 2003).”
BackgroundVascular CaMKII: heart and brain in your arteries
Toussaint, F., Charbel, C., Allen, B. G., & Ledoux, J. (2016) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00341.2015 · Cited by 29
Li, Z., Gu, M., Zaparte, A., Fu, X., Mahen, K. K., Mrdjen, M., Li, X. S., Yang, Z., Ma, J., Thoudam, T., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-55084-2 · Cited by 34
Lapi, D., Vagnani, S., Pignataro, G., Esposito, E., Paterni, M., & Colantuoni, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00099 · Cited by 28
“Moreover, PKC has been suggested to regulate eNOS expression and activity in vascular cells, through different isoform activation (Davda et al., 1994; Fleming et al., 2001; Michell et al., 2001).”
BackgroundZhang, X., Yokoo, H., Nishioka, H., Fujii, H., Matsuda, N., Hayashi, T., & Hattori, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00594.x · Cited by 28
“Several lines of evidence have suggested that eNOS is regulated, in part, through the coordinated phosphorylation and dephosphorylation of the amino acid residues Ser-1177 and Thr-495 (Fulton et al., 1999; Fleming et al., 2001; Harris et al., 2001; Michell et al., 2001).”
BackgroundInfluentialLadurner, A., Atanasov, A. G., Heiß, E. H., Baumgartner, L., Schwaiger, S., Rollinger, J. M., Stuppner, H., & Dirsch, V. M. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.06.029 · Cited by 28
Metadata
- Authors
- Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Venue
- Circulation Research
- Published
- 2001-06-08
- Volume
- 88
- Issue
- 11
- Pages
- E68-75
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2135297555
- Cited by
- 770
- References
- 38
- Citations by year
- 2026: 12 · 2025: 25 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 18 · 2017: 29 · 2016: 30 · 2015: 39 · 2014: 34 · 2013: 28 · 2012: 49
- FWCI
- 23.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart Foundation of Australia
- Deutsche Forschungsgemeinschaft (SFB 553)
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Keywords
- endothelial nitric oxide synthase, calmodulin binding, CaMKII, PP1 phosphatase, calyculin A, bradykinin, protein kinase C, nitric oxide production, endothelial cells, dual phosphorylation, calmodulin-dependent kinase II, calmodulin
- MeSH terms
- Animals, Binding Sites, Bradykinin, Calcium, Calmodulin, Cells, Cultured, Coronary Vessels, Endothelium, Vascular, Enzyme Activation, Enzyme Inhibitors, Humans, Phosphorylation, Precipitin Tests, Protein Kinase C, Proto-Oncogene Proteins, Swine, Threonine, Blotting, Western, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, Nitric Oxide Synthase, Mitogen-Activated Protein Kinases, Proto-Oncogene Proteins c-akt, Nitric Oxide Synthase Type III, Calcium-Calmodulin-Dependent Protein Kinase Type 2, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review